Jiazhi Hu

Jiazhi Hu

Auto-generated profile, based on publicly available information

Jiazhi Hu

State Key Laboratory of Gene Function and Modulation Research, School of Life Sciences, PKU-THU Center for Life Sciences, Peking University, Beijing 100871, China; Peking University Chengdu Academy for Advanced Interdisciplinary Biotechnologies, Chengdu 610213, Sichuan, China

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2014 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
RFRichard L Frock
Richard L Frock
JHJiazhi Hu
Jiazhi Hu
RMRobin M Meyers
Robin M Meyers
YHYu-Jui Ho
Yu-Jui Ho
EKErina Kii
Erina Kii
FAFrederick W Alt
Frederick W Alt
An unbiased genome-wide method reveals on- and off-target DNA cleavage by TALEN and Cas9 nucleases by detecting chromosome translocation events. Although great progress has been made in the characterization of the off-target effects of engineered nucleases, sensitive and unbiased genome-wide methods for the detection of off-target cleavage events and potential collateral damage are still lacking. Here we describe a linear amplification–mediated modification of a previously published high-throughput, genome-wide, translocation sequencing (HTGTS) method that robustly detects DNA double-stranded breaks (DSBs) generated by engineered nucleases across the human genome based on their translocation to other endogenous or ectopic DSBs. HTGTS with different Cas9:sgRNA or TALEN nucleases revealed off-target hotspot numbers for given nucleases that ranged from a few or none to dozens or more, and extended the number of known off-targets for certain previously characterized nucleases more than tenfold. We also identified translocations between bona fide nuclease targets on homologous chromosomes, an undesired collateral effect that has not been described previously. Finally, HTGTS confirmed that the Cas9D10A paired nickase approach suppresses off-target cleavage genome-wide.

31 March 2016 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
JHJiazhi Hu
Jiazhi Hu
RMRobin M Meyers
Robin M Meyers
JDJunchao Dong
Junchao Dong
RPRohit A Panchakshari
Rohit A Panchakshari
FAFrederick W Alt
Frederick W Alt
RFRichard L Frock
Richard L Frock

1 December 2014 in Cell
Verified
Journal Article
Closed access
FMFei-Long Meng
Fei-Long Meng
ZDZhou Du
Zhou Du
AFAlexander Federation
Alexander Federation
JHJiazhi Hu
Jiazhi Hu
Qiao WangQiao Wang
Qiao Wang
FAFrederick W. Alt
Frederick W. Alt

1 November 2015 in Cell
Verified
Journal Article
Closed access
JHJiazhi Hu
Jiazhi Hu
YZYu Zhang
Yu Zhang
LZLijuan Zhao
Lijuan Zhao
RFRichard L Frock
Richard L Frock
ZDZhou Du
Zhou Du
FAFrederick W. Alt
Frederick W. Alt

24 November 2017 in Genome Biology
Verified
Journal Article
Open access
PDF file
EZErwei Zuo
Erwei Zuo
XHXiaona Huo
Xiaona Huo
XYXuan Yao
Xuan Yao
XHXinde Hu
Xinde Hu
YSYidi Sun
Yidi Sun
HYHui Yang
Hui Yang
The CRISPR/Cas9 system has become an efficient gene editing method for generating cells carrying precise gene mutations, including the rearrangement and deletion of chromosomal segments. However, whether an entire chromosome could be eliminated by this technology is still unknown. Here we demonstrate the use of the CRISPR/Cas9 system to eliminate targeted chromosomes. Using either multiple cleavages induced by a single-guide RNA (sgRNA) that targets multiple chromosome-specific sites or a cocktail of multiple sgRNAs, each targeting one specific site, we found that a sex chromosome could be selectively eliminated in cultured cells, embryos, and tissues in vivo. Furthermore, this approach was able to produce a targeted autosome loss in aneuploid mouse embryonic stem cells with an extra human chromosome and human induced pluripotent stem cells with trisomy 21, as well as cancer cells. CRISPR/Cas9-mediated targeted chromosome elimination offers a new approach to develop animal models with chromosome deletions, and a potential therapeutic strategy for human aneuploidy diseases involving additional chromosomes.

1 June 2012 in Cell
Verified
Journal Article
Closed access
JHJiazhi Hu
Jiazhi Hu
LSLei Sun
Lei Sun
FSFenfen Shen
Fenfen Shen
YCYufei Chen
Yufei Chen
YHYu Hua
Yu Hua
DKDaochun Kong
Daochun Kong